Epix Pharmaceuticals Inc: Premium Company Profile

Publication Date	January 2008
Publisher	Datamonitor
Product Type	Databook
Pages	55
ISBN Number	not applicable
Product Code	DAT09410

Price

£265.00
approximately: $532 | €333

PRINT £265 ($532 | €333)

Order above formats by FAX

Summary

Introduction

EPIX Pharmaceuticals is a clinical-stage biopharmaceutical company focused on small molecule drug discovery and development with pipeline of internally-discovered drug candidates currently in clinical development to treat diseases of the central nervous system and lung conditions. The company's lead product, Vasovist is marketed in 32 European nation and waiting for the approval in US.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

EPIX Pharmaceuticals' proprietary development program integrates computational methods with the medical chemistry which addresses the inefficiencies associated with the traditional methods of drug discovery.The company has four therapeutic product candidates in clinical trials for depression, Alzheimer's disease, cardiovascular disease and obesity.

EPIX Pharmaceuticals derives its revenues from royalties, license and collaboration fees. The company's total revenues decreased from $12 million in 2004 to $4 million in 2006.

EPIX Pharmaceuticals' total revenues are forecasted to expand by a CAGR of 66% over the period 2006-2010. The growth is attributed to the royalties, license, collaboration, and others, anticipating the company's business development deals and clinical developments of its early stage drug candidates.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Locations and Subsidiaries
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Business Segment Performance
- Products & Services
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: EPIX Pharmaceutical - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: EPIX Pharmaceuticals - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: EPIX Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 1: EPIX Pharmaceuticals - Key Facts
- Table 2: EPIX Pharmaceuticals - Other Locations and Subsidiaries
- Table 3: EPIX Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 4: EPIX Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 5: EPIX Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 6: EPIX Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 7: EPIX Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 8: EPIX Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 9: EPIX Pharmaceuticals - Revenue Breakdown by Division, 2002-2006 ($ Mn)
- Table 10: EPIX Pharmaceuticals - in-house Pipeline Products
- Table 11: EPIX Pharmaceuticals - Collaboration Pipeline Products
- Table 12: EPIX Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 13: EPIX Pharmaceuticals - Key Competitors
- Table 14: EPIX Pharmaceuticals - Key Suppliers
- Table 15: EPIX Pharmaceuticals - Key Suppliers
- Table 16: EPIX Pharmaceuticals - Key Shareholders
- Table 17: EPIX Pharmaceuticals - SWOT Analysis Summary
- Table 18: EPIX Pharmaceuticals - Value Chain Analysis
- Table 19: EPIX Pharmaceuticals - Scorecard
- Table 20: EPIX Pharmaceuticals - Key Employees
- Table 21: EPIX Pharmaceuticals - Financial and Operational Overview